Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic

被引:9
|
作者
Afroz, Most Alina [1 ]
Schwarber, Grant [2 ]
Bhuiyan, Mohammad Alfrad Nobel [2 ]
机构
[1] Begum Rokeya Univ, Dept Elect & Elect Engn, Rangpur, Bangladesh
[2] Medpace Inc, Dept Biostat, 5375 Medpace Way, Cincinnati, OH 45227 USA
关键词
Centralize data monitoring; Risk based data monitoring; DATA QUALITY;
D O I
10.1016/j.cct.2021.106368
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: COVID-19 pandemic caused several alarming challenges for clinical trials. On-site source data verification (SDV) in the multicenter clinical trial became difficult due to travel ban and social distancing. For multicenter clinical trials, centralized data monitoring is an efficient and cost-effective method of data monitoring. Centralized data monitoring reduces the risk of COVID-19 infections and provides additional capabilities compared to on-site monitoring. The key steps for on-site monitoring include identifying key risk factors and thresholds for the risk factors, developing a monitoring plan, following up the risk factors, and providing a management plan to mitigate the risk. Methods: For analysis purposes, we simulated data similar to our clinical trial data. We classified the data monitoring process into two groups, such as the Supervised analysis process, to follow each patient remotely by creating a dashboard and an Unsupervised analysis process to identify data discrepancy, data error, or data fraud. We conducted several risk-based statistical analysis techniques to avoid on-site source data verification to reduce time and cost, followed up with each patient remotely to maintain social distancing, and created a centralized data monitoring dashboard to ensure patient safety and maintain the data quality. Conclusion: Data monitoring in clinical trials is a mandatory process. A risk-based centralized data review process is cost-effective and helpful to ignore on-site data monitoring at the time of the pandemic. We summarized how different statistical methods could be implemented and explained in SAS to identify various data error or fabrication issues in multicenter clinical trials.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Oncology Clinical Trials During the COVID-19 Pandemic
    Lara Gongora, Aline Bobato
    Fontes Jardim, Denis Leonardo
    Bastos, Diogo Assed
    ONCOLOGY-NEW YORK, 2020, 34 (07): : 265 - 269
  • [22] The COVID-19 pandemic: a catalyst to improve clinical trials
    Prakriti Gaba
    Deepak L. Bhatt
    Nature Reviews Cardiology, 2020, 17 : 673 - 675
  • [23] Treatments in the COVID-19 pandemic: an update on clinical trials
    Tao, Yanyi
    Tang, Liang V.
    Hu, Yu
    EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (02) : 81 - 88
  • [24] Conducting clinical trials during the COVID-19 pandemic
    Collier, Erin K.
    Hsiao, Jennifer L.
    Shi, Vivian Y.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 330 - 332
  • [25] Impact of the COVID-19 pandemic on clinical trials with drugs
    Hasford, Joerg
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (11) : 1373 - 1375
  • [26] The COVID-19 pandemic: a catalyst to improve clinical trials
    Gaba, Prakriti
    Bhatt, Deepak L.
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (11) : 673 - 675
  • [27] Impact of the COVID-19 Pandemic on Cancer Clinical Trials
    Boughey, Judy C.
    Snyder, Rebecca A.
    Kantor, Olga
    Zheng, Linda
    Chawla, Akhil
    Nguyen, Toan T.
    Hillman, Shauna L.
    Hahn, Olwen M.
    Mandrekar, Sumithra J.
    Roland, Christina L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7311 - 7316
  • [28] The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
    Bagiella, Emilia
    Bhatt, Deepak L.
    Gaudino, Mario
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 342 - 345
  • [29] Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
    Audisio, Katia
    Lia, Hillary
    Robinson, Newell Bryce
    Rahouma, Mohamed
    Soletti Jr, Giovanni
    Cancelli, Gianmarco
    Perezgrovas Olaria, Roberto
    Chadow, David
    Tam, Derrick Y.
    Vervoort, Dominique
    Farkouh, Michael E.
    Bhatt, Deepak L.
    Fremes, Stephen E.
    Gaudino, Mario
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (01)
  • [30] A Risk-Based Approach to the COVID-19 Pandemic: The Experience in National Dental Centre Singapore
    Tay, John Rong Hao
    Ng, Ethan
    Ong, Marianne Meng Ann
    Sim, Chelsia
    Tan, Ken
    Seneviratne, Chaminda Jayampath
    FRONTIERS IN MEDICINE, 2020, 7